These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15893774)
1. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor. Garai J; Lóránd T; Molnár V Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774 [TBL] [Abstract][Full Text] [Related]
2. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones. Garai J; Molnár V; Eros D; Orfi L; Lóránd T Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice. Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition. Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941 [TBL] [Abstract][Full Text] [Related]
5. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113 [TBL] [Abstract][Full Text] [Related]
6. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846 [TBL] [Abstract][Full Text] [Related]
8. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity. Cheng KF; Al-Abed Y Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188 [TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors. Orita M; Yamamoto S; Katayama N; Fujita S Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220 [TBL] [Abstract][Full Text] [Related]
10. Estrogen-inducible uterine flavonoid binding sites: is it time to reconsider? Garai J; Adlercreutz H J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):377-81. PubMed ID: 15145447 [TBL] [Abstract][Full Text] [Related]
11. Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism. Soares T; Goodsell D; Ferreira R; Olson AJ; Briggs JM J Mol Recognit; 2000; 13(3):146-56. PubMed ID: 10867710 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069 [TBL] [Abstract][Full Text] [Related]
14. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. Kleemann R; Kapurniotu A; Frank RW; Gessner A; Mischke R; Flieger O; Jüttner S; Brunner H; Bernhagen J J Mol Biol; 1998 Jul; 280(1):85-102. PubMed ID: 9653033 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoate. Golubkov PA; Johnson WH; Czerwinski RM; Person MD; Wang SC; Whitman CP; Hackert ML Bioorg Chem; 2006 Aug; 34(4):183-99. PubMed ID: 16780921 [TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments. Garai J; Lóránd T Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Stamps SL; Fitzgerald MC; Whitman CP Biochemistry; 1998 Jul; 37(28):10195-202. PubMed ID: 9665726 [TBL] [Abstract][Full Text] [Related]
19. Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor. Trivedi-Parmar V; Jorgensen WL J Med Chem; 2018 Sep; 61(18):8104-8119. PubMed ID: 29812929 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]